Prognostic Role of Tumor Microenvironment in DLBCL and Relation to Patients’ Clinical Outcome: A Clinical and Immunohistochemical Study

Prognostic Role of Tumor Microenvironment in DLBCL and Relation to Patients’ Clinical Outcome: A Clinical and Immunohistochemical Study

Diffuse large B cell lymphoma is the most common type of lymphoma in Egypt with an unfavorable prognosis. The tumor microenvironment is rich in immune response either T cells or macrophages. The current study is aimed at testing CD4, CD8, CD68, and MMP9 immunohistochemistry of DLBCL activities with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Doaa Shams-Deen Ghorab, Ahmed Mohamed Helaly, Hoda Saleh El Mahdi, Moawiah Khatatbeh, Afaf Taha Ibrahiem
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Analytical Cellular Pathology
Online Access:	http://dx.doi.org/10.1155/2022/9993496
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Prognostic Value of the Immunohistochemical Detection of Cellular Components of the Tumor Microenvironment in Oral Squamous Cell Carcinoma: A Systematic Review
by: Hannah Gil de Farias Morais, et al.
Published: (2025-07-01)

Regulation and therapy: the role of ferroptosis in DLBCL
by: Yifan Wang, et al.
Published: (2025-01-01)

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
by: Riccardo Moia, et al.
Published: (2025-04-01)

Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
by: Aimilia Vareli, et al.
Published: (2025-08-01)

Immunohistochemical study of uveal melanoma and its cellular microenvironment
by: S. V. Saakyan, et al.
Published: (2022-06-01)

Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment
by: Alon Vigdorovits, et al.
Published: (2024-11-01)

CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients
by: Lingyu Zhang, et al.
Published: (2025-05-01)

Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients
by: Qing Shi, et al.
Published: (2017-01-01)

Analysis of m7G-related signatures in the tumor immune microenvironment and identification of clinical prognostic regulators in ovarian cancer
by: Kunyu Wang, et al.
Published: (2025-08-01)

Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy
by: Yihan Yu, et al.
Published: (2025-09-01)

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
by: Qinglong Ma, et al.
Published: (2025-01-01)

Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer
by: Xiangyang He, et al.
Published: (2025-02-01)

Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
by: Yang Wang, et al.
Published: (2025-05-01)

Clinical, Histological, Immunohistochemical Aspects in a Rare Malignant Peripheral Nerve Sheath (Triton) Tumor
by: Laura REBEGEA, et al.
Published: (2021-03-01)

Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL
by: Tingting Zhang, et al.
Published: (2022-04-01)

Morphological and immunohistochemical analysis of tumor-infiltrating lymphocytes, M2 macrophages, BCL 6 and SOX10 in the tumor microenvironment of nodular cutaneous melanoma
by: K. S. Titov, et al.
Published: (2023-06-01)

Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression
by: Jiaxing Guo, et al.
Published: (2025-05-01)

Constructing a tumor immune microenvironment-driven prognostic model in acute myeloid leukemia using bioinformatics and validation data
by: Amir Abbas Navidinia, et al.
Published: (2025-07-01)

SEPT9 and PAI-1 are immunohistochemical biomarkers of the hepatocellular carcinoma immune microenvironment
by: Eundong Park, et al.
Published: (2025-04-01)

Prognostic factors and survival outcomes of immunohistochemically detection based-molecular subtypes of endometrial cancer–analysis of 576 clinical cases
by: Xiaohui Wang, et al.
Published: (2024-12-01)

The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications
by: Masato Nakajima, et al.
Published: (2017-04-01)

Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication
by: Hua Wang, et al.
Published: (2024-11-01)

Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications
by: Hao Peng, et al.
Published: (2025-01-01)

Beclin-1 as a potential prognostic marker in correlation with E-cadherin in oral lichen planus and oral squamous cell carcinoma: an immunohistochemical analysis
by: Heba N. Shalash, et al.
Published: (2024-12-01)

5-Hydroxymethylcytosine profilings in circulating cell-free DNA as diagnostic biomarkers for DLBCL
by: Hangyu Chen, et al.
Published: (2024-11-01)

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
by: Valerie Chew, et al.
Published: (2020-10-01)

Identification of immune-related cervical cancer prognostic biomarkers and construction of prognostic model based on tumor microenvironment
by: Qiufang Bao, et al.
Published: (2025-04-01)

Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax
by: Caroline A. Coughlin, et al.
Published: (2025-02-01)

Diversity of mast cell subpopulations in the tumor microenvironment of colorectal cancer and their prognostic implications
by: Tianyu Qiao, et al.
Published: (2025-06-01)

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms
by: Zhijiang Chen, et al.
Published: (2024-10-01)

Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures
by: Jianye Tan, et al.
Published: (2022-01-01)

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
by: Junshu Li, et al.
Published: (2024-12-01)

Exosome-mediated ferroptosis in the tumor microenvironment: from molecular mechanisms to clinical application
by: Na Liu, et al.
Published: (2025-05-01)

Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancer
by: Jefim Brodkin, et al.
Published: (2024-12-01)

Histopathological and immunohistochemical aspects of the oropharyngeal neoplasm in the ENT Clinic, Craiova
by: Ioana-Cristina Oprişcan, et al.
Published: (2023-01-01)

Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
by: Lorenza Bridi Todeschini, et al.
Published: (2025-01-01)

Morphofunctional and immunohistochemical characteristics of different clinical-pathogenetic types of leyiomyoma
by: N. V. Kosey, et al.
Published: (2017-12-01)

Construction and immunohistochemical validation of a necroptosis-related prognostic signature in bladder cancer and its association with tumor immune infiltration
by: Tao Wang, et al.
Published: (2025-08-01)

Identification and validation of a prognostic signature related to hypoxic tumor microenvironment in cervical cancer.
by: Chenyu Nie, et al.
Published: (2022-01-01)